Adipose Stem Cell treatment is a short-term procedure that is performed on an outpatient basis in the Surgical Department of Clínica Vertebra. Obtaining Adipose-Derived Stem Cells (ADSCs) is less invasive than performing a bone marrow harvest.
Adipose tissue contains a much larger volume of Mesenchymal Stem Cells than bone marrow.
We use the patient’s own adipose tissue to extract the stem cells needed for the treatment.
Our technology allows us to complete the entire procedure on the same day, using minimally manipulative methods and most importantly, in complete safety.
The entire Stem Cell Therapy process can be completed in 2 to 3 hours. There is no need to send samples to an outside laboratory and wait days for the Stem Cells to return for intravenous injection or other percutaneous surgical procedure. This accelerated process provides an increase in Stem Cell counts without manipulation.
The treatment process is performed in 4 stages:
- Therapeutic Inoculation
A small amount of fat (50 cc – 200 cc) is obtained from the area of the waist or upper buttock of the patient, being the method similar to liposuction performed by a specialist in Surgery, under intravenous sedation and control by an anesthesiologist specialist, in an operating room duly accredited by the Department of Health (Generalitat de Catalunya).
The collection of stem cells derived from adipose tissue (ADSC) is a much simpler procedure than its extraction from bone marrow, since adipose tissue contains larger volumes of stem cells than bone marrow. By using the patient’s own adipose tissue to extract the stem cells, it means that the donor and the recipient are the same person, so there is no danger of host rejection. It is therefore an autologous treatment or a cellular transplant.
The Stem Cells are separated from the adipose tissue cells in the Stem Cell centrifuge machine at high speed, where the centrifugal force separates the dormant Stem Cells from the harvested fat tissue.
Once the Stem Cells are isolated and after enrichment with the patient’s blood plasma, they are enzymatically activated and prepared for transfer to the patient.
4. THERAPEUTIC INOCULATION
The activated Stem Cells are added to the saline drip bag and returned to the patient’s body through a standard intravenous drip, while the patient is resting, or they are percutaneously inoculated into the damaged region of the body.
The therapeutic action is a complex process, involving mechanisms at the molecular and cellular level, but in summary we could simplify it as follows: when the activated Stem Cells are returned to the patient’s body, they are circulating in the vascular system for a short period of time until they are attracted to the proteins that are secreted in the area of the damaged tissue. The Stem Cells precipitate into the injured area, and become the new healthy tissue. When they are inoculated into the damaged tissue, the process is direct to the therapeutic target.
Numerous pathological conditions and diseases lead to disorders of metabolism, impairment of the immune system and increased generation of free radicals.
Standard medical practice uses a large number of pharmacological agents that reduce the body’s natural capacity for self-defense and regeneration, leading to disruption of metabolic and immunological processes, hemodynamics and the cell’s regenerative capacity.
Stem cells, as undifferentiated cells, potentially recover the normal processes of organ homeostasis.
In order to increase their volume and resistance, and to improve the possibilities of implantation, we must first detoxify the organism, accelerate its regenerative processes and reduce the symptoms of the disease being treated.